"Pseudomonas Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infections with bacteria of the genus PSEUDOMONAS.
Descriptor ID |
D011552
|
MeSH Number(s) |
C01.252.400.739
|
Concept/Terms |
Pseudomonas Infections- Pseudomonas Infections
- Infections, Pseudomonas
- Infection, Pseudomonas
- Pseudomonas Infection
|
Below are MeSH descriptors whose meaning is more general than "Pseudomonas Infections".
Below are MeSH descriptors whose meaning is more specific than "Pseudomonas Infections".
This graph shows the total number of publications written about "Pseudomonas Infections" by people in this website by year, and whether "Pseudomonas Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1996 | 1 | 0 | 1 |
1997 | 0 | 1 | 1 |
2002 | 1 | 2 | 3 |
2004 | 0 | 1 | 1 |
2005 | 2 | 0 | 2 |
2006 | 1 | 0 | 1 |
2007 | 0 | 1 | 1 |
2008 | 2 | 0 | 2 |
2009 | 1 | 0 | 1 |
2010 | 2 | 3 | 5 |
2011 | 4 | 2 | 6 |
2012 | 1 | 1 | 2 |
2013 | 0 | 2 | 2 |
2014 | 1 | 1 | 2 |
2015 | 4 | 0 | 4 |
2016 | 4 | 0 | 4 |
2017 | 2 | 0 | 2 |
2018 | 1 | 0 | 1 |
2019 | 6 | 1 | 7 |
2020 | 4 | 1 | 5 |
2021 | 3 | 0 | 3 |
2022 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pseudomonas Infections" by people in Profiles.
-
Antipseudomonal treatment decisions during CF exacerbation management. J Cyst Fibros. 2022 09; 21(5):753-758.
-
Rapid expansion and extinction of antibiotic resistance mutations during treatment of acute bacterial respiratory infections. Nat Commun. 2022 03 09; 13(1):1231.
-
Poly (acetyl, arginyl) glucosamine disrupts Pseudomonas aeruginosa biofilms and enhances bacterial clearance in a rat lung infection model. Microbiology (Reading). 2022 01; 168(1).
-
Alcaligenes faecalis metallo-?-lactamase in extensively drug-resistant Pseudomonas aeruginosa isolates. Clin Microbiol Infect. 2022 Jun; 28(6):880.e1-880.e8.
-
Management of chronic Pseudomonas aeruginosa infection with inhaled levofloxacin in people with cystic fibrosis. Future Microbiol. 2021 09; 16:1087-1104.
-
Immunoglobulin GM and KM allotypes are associated with antibody responses to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients. J Cyst Fibros. 2021 11; 20(6):1080-1084.
-
Use of continuous-infusion ceftolozane/tazobactam for resistant Gram-negative bacterial infections: a retrospective analysis and brief review of the literature. Int J Antimicrob Agents. 2020 Nov; 56(5):106158.
-
Antimicrobial resistance: Concerns of healthcare providers and people with CF. J Cyst Fibros. 2021 05; 20(3):407-412.
-
Culture of Small Colony Variant of Pseudomonas aeruginosa and Quantitation of its Alginate. J Vis Exp. 2020 02 22; (156).
-
Generation of In-Frame Gene Deletion Mutants in Pseudomonas aeruginosa and Testing for Virulence Attenuation in a Simple Mouse Model of Infection. J Vis Exp. 2020 01 08; (155).